MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
*Organization & Developments: Biodelivery (2012-2017)
Parents
Archives & Legacy
Organization & Developments: Biodelivery
Children
2012: Chronic pain treatment from BDSI licensed to Endo Pharma in $180M deal (2012)
2016: BioDelivery Sciences: $2.50 Biopharma Still Looks Poised To Double After Earnings - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2016: BioDelivery's Clonidine Topical Gel flunks mid-stage study in diabetic neuropathy; shares drop 30% premarket - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2016: Biotech Forum Daily Digest: The Donald Chimes In, Revisiting The Investment Case On BioDelivery Sciences
2017: BioDelivery Sciences: ~$2 Biopharma Stock On The Cusp Of A Turnaround - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2017: BioDelivery Sciences: 2017 Will Be Key Year For ~$2 Biopharma - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2017: BioDelivery Sciences: Belbuca Transition Appears To Have Worked - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2017: BSDI 2016 Annual Report to Stockholders
2017: VA_65--BioDelivery Sciences International, Inc. Effective Date: 06-01-2017 through 05-31-2021